[{"address1": "455 Mission Bay Boulevard South", "city": "San Francisco", "state": "CA", "zip": "94158", "country": "United States", "phone": "415 482 5300", "fax": "415 339 5300", "website": "https://www.nektar.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing therapies that selectively modulate the immune system to treat autoimmune disorders in the United States and internationally. It develops NKTR-358, a regulatory T (Treg) cell stimulator designed to address the imbalance in the immune system underlying autoimmune disorders and chronic inflammatory conditions; PEG-CSF1, a polyethylene glycol (PEG) modified hematopoietic colony stimulating factor protein that is engineered to selectively modulate resolution processes of inflammation and has applications in a number of therapeutic indications, including acute and chronic inflammation; Tumor necrosis factor (TNF) receptor type II (TNFR2) agonist asset is a bivalent antibody molecule used to selectively stimulate TNFR2 receptor activity, without modulation of the TNFR1 signaling; and NKTR-255, an IL-15 receptor agonist designed to boost the immune system's natural ability to fight cancer. It has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; Merck KGaA; and SFJ Pharmaceuticals, Inc. The company was incorporated in 1990 and is headquartered in San Francisco, California.", "fullTimeEmployees": 61, "companyOfficers": [{"maxAge": 1, "name": "Mr. Howard W. Robin", "age": 71, "title": "CEO, President & Director", "yearBorn": 1953, "fiscalYear": 2024, "totalPay": 2166571, "exercisedValue": 0, "unexercisedValue": 186333}, {"maxAge": 1, "name": "Ms. Sandra A. Gardiner", "age": 58, "title": "CFO and Principal Financial & Accounting Officer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 460850, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark A. Wilson J.D.", "age": 52, "title": "Senior VP, Chief Legal Officer & Secretary", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 898297, "exercisedValue": 0, "unexercisedValue": 46583}, {"maxAge": 1, "name": "Dr. Jonathan  Zalevsky Ph.D.", "age": 49, "title": "Senior VP and Chief Research & Development Officer", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 1151200, "exercisedValue": 0, "unexercisedValue": 35833}, {"maxAge": 1, "name": "Mr. Jason  Barnard", "title": "Chief Accounting Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Bacci", "title": "Chief People Officer and Head of Quality & Facilities", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer  Ruddock", "title": "Chief Business Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Brian L. Kotzin M.D.", "age": 74, "title": "Interim Chief Medical Officer", "yearBorn": 1950, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 2, "overallRisk": 5, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://ir.nektar.com/", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 25.84, "open": 25.08, "dayLow": 24.1899, "dayHigh": 25.74, "regularMarketPreviousClose": 25.84, "regularMarketOpen": 25.08, "regularMarketDayLow": 24.1899, "regularMarketDayHigh": 25.74, "payoutRatio": 0.0, "beta": 0.556, "forwardPE": -32.337795, "volume": 3211172, "regularMarketVolume": 3211172, "averageVolume": 1505745, "averageVolume10days": 8117400, "averageDailyVolume10Day": 8117400, "bid": 23.09, "ask": 28.27, "bidSize": 5, "askSize": 1, "marketCap": 308933056, "fiftyTwoWeekLow": 6.45, "fiftyTwoWeekHigh": 37.38, "priceToSalesTrailing12Months": 3.5408611, "fiftyDayAverage": 11.8596, "twoHundredDayAverage": 14.34915, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 288621600, "profitMargins": -1.5248599, "floatShares": 12233960, "sharesOutstanding": 12406900, "sharesShort": 595786, "sharesShortPriorMonth": 710759, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.048, "heldPercentInsiders": 0.0128999995, "heldPercentInstitutions": 0.67111, "shortRatio": 2.36, "shortPercentOfFloat": 0.0495, "impliedSharesOutstanding": 14294900, "bookValue": 1.107, "priceToBook": 22.493317, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -133041000, "trailingEps": -9.45, "forwardEps": -0.77, "lastSplitFactor": "1:15", "lastSplitDate": 1749427200, "enterpriseToRevenue": 3.308, "enterpriseToEbitda": -2.113, "52WeekChange": 0.47236466, "SandP52WeekChange": 0.12632763, "lastDividendValue": 0.0, "lastDividendDate": 1402444800, "quoteType": "EQUITY", "currentPrice": 24.9001, "targetHighPrice": 120.0, "targetLowPrice": 69.0, "targetMeanPrice": 96.8, "targetMedianPrice": 100.0, "recommendationMean": 1.875, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 218632000, "totalCashPerShare": 17.622, "ebitda": -136622000, "totalDebt": 186659008, "quickRatio": 3.107, "currentRatio": 3.241, "totalRevenue": 87248000, "debtToEquity": 1358.706, "revenuePerShare": 6.241, "returnOnAssets": -0.26798, "returnOnEquity": -1.89459, "grossProfits": 65096000, "freeCashflow": -47842876, "operatingCashflow": -176874000, "revenueGrowth": -0.517, "grossMargins": 0.7461, "ebitdaMargins": -1.5659, "operatingMargins": -4.24149, "financialCurrency": "USD", "symbol": "NKTR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NCM", "messageBoardId": "finmb_29929", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -3.6373818, "regularMarketPrice": 24.9001, "corporateActions": [], "regularMarketTime": 1751395995, "marketState": "REGULAR", "shortName": "Nektar Therapeutics", "longName": "Nektar Therapeutics", "epsCurrentYear": -11.18599, "priceEpsCurrentYear": -2.2260077, "fiftyDayAverageChange": 13.040501, "fiftyDayAverageChangePercent": 1.0995734, "twoHundredDayAverageChange": 10.550951, "twoHundredDayAverageChangePercent": 0.7353015, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.9 - Buy", "cryptoTradeable": false, "epsForward": -0.77, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 767971800000, "regularMarketChange": -0.93989944, "regularMarketDayRange": "24.1899 - 25.74", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1505745, "fiftyTwoWeekLowChange": 18.4501, "fiftyTwoWeekLowChangePercent": 2.8604808, "fiftyTwoWeekRange": "6.45 - 37.38", "fiftyTwoWeekHighChange": -12.4799, "fiftyTwoWeekHighChangePercent": -0.3338657, "fiftyTwoWeekChangePercent": 47.236465, "earningsTimestamp": 1746735304, "earningsTimestampStart": 1754510400, "earningsTimestampEnd": 1754942400, "earningsCallTimestampStart": 1746738000, "earningsCallTimestampEnd": 1746738000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -9.45, "trailingPegRatio": null, "__fetch_time": "2025-07-01"}]